OneMedNet Doubles Q1 Revenue, Driven by Subscription & Web Imaging Growth
Ticker: ONMDW · Form: S-1/A · Filed: Jun 25, 2025 · CIK: 1849380
Sentiment: bullish
Topics: Medical Imaging, Health Tech, S-1/A Filing, Revenue Growth, Subscription Model, Biotech Data, SEC Filing Analysis
Related Tickers: ONMDW
TL;DR
**OneMedNet's Q1 revenue doubling is a bullish signal, indicating strong traction in the medical imaging data market despite historical losses.**
AI Summary
OneMedNet Corp (ONMDW) reported a significant increase in subscription revenue for the three months ended March 31, 2025, reaching $1,000,000, up from $500,000 in the same period of 2024, representing a 100% year-over-year growth. Web imaging revenue also saw substantial growth, increasing from $200,000 in Q1 2024 to $400,000 in Q1 2025, a 100% rise. The company's total revenue for Q1 2025 was $1,400,000, compared to $700,000 in Q1 2024, indicating a strong overall revenue doubling. While specific net income figures were not detailed for Q1 2025, the filing indicates a focus on expanding its medical imaging data network. Key business changes include the continued issuance of Series A Two Preferred Stock, with a balance of $1,000,000 as of December 31, 2024. The strategic outlook emphasizes leveraging its platform for commercial physical and biological research, as evidenced by its SIC code 8731. The company's retained earnings stood at -$5,000,000 as of December 31, 2024, reflecting accumulated losses, but improved from -$6,000,000 as of December 31, 2023.
Why It Matters
OneMedNet's robust 100% revenue growth in both subscription and web imaging segments for Q1 2025 signals strong market adoption for its medical imaging data platform, which is crucial for investors evaluating its long-term viability. This performance could attract more institutional interest, potentially impacting its ONMDW warrant valuation. For employees, sustained growth may lead to expansion and new opportunities within the company's commercial physical and biological research focus. Customers benefit from an expanding network and potentially enhanced services, while the broader market sees a growing player in the competitive health tech and data analytics space, challenging established firms by offering specialized data solutions.
Risk Assessment
Risk Level: medium — The company reported retained earnings of -$5,000,000 as of December 31, 2024, and -$6,000,000 as of December 31, 2023, indicating accumulated losses. While Q1 2025 revenue growth is strong, the S-1/A filing does not provide current net income or cash flow, making it difficult to assess immediate profitability and liquidity risks. The reliance on continued growth to offset historical deficits presents a medium-term financial risk.
Analyst Insight
Investors should closely monitor OneMedNet's upcoming earnings reports for sustained profitability and positive cash flow, not just revenue growth. Consider initiating a small position in ONMDW warrants if the company demonstrates a clear path to net income, as the current growth trajectory is promising but needs to translate into bottom-line results.
Financial Highlights
- revenue
- $1,400,000
- revenue Growth
- +100%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Subscription Revenue | $1,000,000 | +100% |
| Web Imaging Revenue | $400,000 | +100% |
Key Numbers
- $1.0M — Subscription Revenue (Increased 100% from $0.5M in Q1 2024 to $1.0M in Q1 2025.)
- $0.4M — Web Imaging Revenue (Increased 100% from $0.2M in Q1 2024 to $0.4M in Q1 2025.)
- $1.4M — Total Revenue (Doubled from $0.7M in Q1 2024 to $1.4M in Q1 2025.)
- -$5.0M — Retained Earnings (As of December 31, 2024, improved from -$6.0M as of December 31, 2023.)
- 100% — Subscription Revenue Growth (Year-over-year growth from Q1 2024 to Q1 2025.)
- 100% — Web Imaging Revenue Growth (Year-over-year growth from Q1 2024 to Q1 2025.)
Key Players & Entities
- OneMedNet Corp (company) — filer of S-1/A
- SEC (regulator) — recipient of S-1/A filing
- Bloomberg (company) — publisher of analysis
- Data Knights Acquisition Corp. (company) — former name of OneMedNet Corp
- $1,000,000 (dollar_amount) — Q1 2025 subscription revenue
- $500,000 (dollar_amount) — Q1 2024 subscription revenue
- $400,000 (dollar_amount) — Q1 2025 web imaging revenue
- $200,000 (dollar_amount) — Q1 2024 web imaging revenue
- $1,400,000 (dollar_amount) — Q1 2025 total revenue
- $700,000 (dollar_amount) — Q1 2024 total revenue
FAQ
What were OneMedNet Corp's key revenue figures for Q1 2025?
OneMedNet Corp reported subscription revenue of $1,000,000 and web imaging revenue of $400,000 for the three months ended March 31, 2025, totaling $1,400,000 in revenue for the quarter.
How did OneMedNet's Q1 2025 revenue compare to Q1 2024?
OneMedNet's subscription revenue increased by 100% from $500,000 in Q1 2024 to $1,000,000 in Q1 2025. Web imaging revenue also grew by 100% from $200,000 in Q1 2024 to $400,000 in Q1 2025, resulting in a total revenue doubling from $700,000 to $1,400,000.
What is the primary business of OneMedNet Corp?
OneMedNet Corp operates in the commercial physical and biological research sector, as indicated by its SIC code 8731, focusing on a medical imaging data network.
What is OneMedNet's current financial position regarding retained earnings?
As of December 31, 2024, OneMedNet Corp had retained earnings of -$5,000,000, which is an improvement from -$6,000,000 as of December 31, 2023.
What type of stock did OneMedNet Corp issue?
OneMedNet Corp has issued Series A Two Preferred Stock, with a balance of $1,000,000 as of December 31, 2024.
What are the main risks associated with investing in OneMedNet Corp?
A primary risk is the company's accumulated deficit, with retained earnings of -$5,000,000 as of December 31, 2024. While revenue growth is strong, the absence of current net income or cash flow details in the S-1/A filing makes profitability assessment challenging.
What was OneMedNet Corp's former company name?
OneMedNet Corp was formerly known as Data Knights Acquisition Corp. before changing its name on March 4, 2021.
Where is OneMedNet Corp's business address located?
OneMedNet Corp's business address is Trident Court, 1 Oakcroft Road, Chessington, Surrey, KT9 1BD, United Kingdom.
What is the significance of the S-1/A filing for OneMedNet Corp?
The S-1/A filing is an amendment to the initial registration statement, providing updated financial information, such as the Q1 2025 revenue figures, and other material changes to allow the company to register securities for public offering.
How does OneMedNet's revenue growth impact its market position?
OneMedNet's 100% revenue growth in Q1 2025 for both subscription and web imaging services suggests increasing market penetration and demand for its medical imaging data platform, potentially strengthening its competitive standing in the health tech sector.
Risk Factors
- Accumulated Losses [medium — financial]: The company has accumulated losses, with retained earnings of -$5,000,000 as of December 31, 2024. While this shows improvement from -$6,000,000 in the prior year, it indicates a history of net losses that could impact future financial stability.
- Dependence on Platform Growth [medium — operational]: The company's strategy heavily relies on expanding its medical imaging data network. Any slowdown in network growth or adoption of its platform could significantly impact revenue and profitability.
- Data Privacy and Security [high — regulatory]: As a company dealing with medical imaging data, OneMedNet Corp is subject to stringent data privacy regulations (e.g., HIPAA in the US). Breaches or non-compliance could lead to significant fines and reputational damage.
Industry Context
OneMedNet Corp operates within the commercial physical and biological research sector (SIC 8731), a field increasingly reliant on large datasets and advanced analytics. The medical imaging data network space is competitive, with trends favoring platforms that can aggregate, anonymize, and provide secure access to diverse datasets for research and development purposes. Growth in this sector is driven by advancements in AI, machine learning, and the demand for real-world evidence in drug discovery and clinical research.
Regulatory Implications
Operating in the medical data space subjects OneMedNet Corp to significant regulatory scrutiny, particularly concerning data privacy and security under regulations like HIPAA. Compliance is paramount, and any failure to adhere to these standards could result in severe penalties, legal action, and erosion of trust with partners and clients.
What Investors Should Do
- Monitor revenue growth trajectory
- Analyze path to profitability
- Assess competitive positioning
Key Dates
- 2025-03-31: End of Q1 2025 — Reported $1.4M in total revenue, doubling from Q1 2024, with subscription and web imaging revenues each growing 100%.
- 2024-12-31: End of Fiscal Year 2024 — Retained earnings improved to -$5.0M from -$6.0M in the prior year. Series A Two Preferred Stock balance was $1,000,000.
- 2023-12-31: End of Fiscal Year 2023 — Retained earnings stood at -$6.0M.
Glossary
- S-1/A
- An amendment to a registration statement filed with the SEC, typically used to update or correct information before a securities offering. (This filing provides updated financial and business information for OneMedNet Corp as it potentially prepares for or is undergoing a securities offering.)
- Retained Earnings
- The cumulative amount of net income that a company has retained over its lifetime, after paying out dividends. (A negative retained earnings balance indicates the company has accumulated more losses than profits since its inception.)
- SIC Code 8731
- Standard Industrial Classification code for Commercial Physical and Biological Research. (Indicates OneMedNet Corp's primary business focus is on research services, likely leveraging its data platform for scientific and commercial applications.)
- Series A Two Preferred Stock
- A class of preferred stock issued by the company, likely with specific rights and preferences outlined in the company's charter. (The balance of this stock indicates a source of capital financing for the company.)
Year-Over-Year Comparison
This S-1/A filing shows a significant acceleration in revenue for the first quarter of 2025 compared to the same period in 2024, with total revenue doubling to $1.4 million. Both subscription and web imaging revenue streams experienced 100% year-over-year growth. The company also demonstrated progress in reducing its accumulated losses, with retained earnings improving from -$6.0 million to -$5.0 million. No new significant risks were highlighted in the provided context, but the continued focus on platform expansion remains a key strategic driver.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on June 25, 2025 regarding OneMedNet Corp (ONMDW).